Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
US NCI Sponsors Senhwa Biosciences' Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma 2025-08-07 14:35
FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS) 2025-08-06 20:00
The U.S. FDA Granted Fast Track Designation to Dizal's Birelentinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 2025-08-06 19:02
From AI to Precision Medicine: Taiwan's Smart Healthcare Innovations Shine at Taiwan Expo USA 2025 2025-08-06 10:43
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year 2025-08-06 08:00
Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award" 2025-08-05 22:00
FigureLabs: World's First AI scientific illustration tool for Effortless Publication Figures 2025-08-05 21:00
BON Announces Reciept of Nasdaq Compliance Letter 2025-08-05 21:00
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application 2025-08-05 20:00
Court Sides with Cardiovalve in Edwards patent spat 2025-08-05 20:00
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight 2025-08-05 18:50
Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors 2025-08-05 16:30
WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity 2025-08-05 10:13
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032 2025-08-05 08:00
Pulsecare Medical Announces NMPA Approval of NxPFA™, the World's First Nanosecond PFA System, Ushering in the PFA 3.0 Era 2025-08-04 21:30
Vatech Introduces 'Clever One' - A Game-Changing Dental Viewer Solution for the U.S. Market. 2025-08-04 21:00
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease 2025-08-04 14:29
Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma 2025-08-04 13:56
United Imaging Teases Multi-modality "Provider Success" Product Launches at AHRA 2025 2025-08-04 00:22
Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA 2025-08-01 22:00
1 19 20 21 22 23 491